One hundred years of animal virology
... SIVagm and SIVsm, both of which have been shown to cause immunodeficiency in heterologous species, do not induce disease in their respective natural hosts. This indicates that the natural hosts are not susceptible to the immunosuppressive effect of the virus and provides hope that new opportunities ...
... SIVagm and SIVsm, both of which have been shown to cause immunodeficiency in heterologous species, do not induce disease in their respective natural hosts. This indicates that the natural hosts are not susceptible to the immunosuppressive effect of the virus and provides hope that new opportunities ...
Use of virus-like particles for therapeutic vaccination
... • Replications-incompetent vaccines (eg Alphavirus-based vaccines) • Reassortant viruses (chimeras between human and non-human viruses) • Attenuation of pathogens by making them more immunogenic (eg IL-2 expressing vaccinia virus; listeriolysin expressing BCG) ...
... • Replications-incompetent vaccines (eg Alphavirus-based vaccines) • Reassortant viruses (chimeras between human and non-human viruses) • Attenuation of pathogens by making them more immunogenic (eg IL-2 expressing vaccinia virus; listeriolysin expressing BCG) ...
New Drugs for Protozoan Parasites
... New Paradigm for Drug Development • Non-profit Drug Company – Private/Govt. Funded – 100s of Scientists – Chemistry – Pharmacokinetics – Toxicology – Phase I, II, III ...
... New Paradigm for Drug Development • Non-profit Drug Company – Private/Govt. Funded – 100s of Scientists – Chemistry – Pharmacokinetics – Toxicology – Phase I, II, III ...
C23L3 PPT - Destiny High School
... For some diseases you only need to be vaccinated once in your life. For other diseases you need to be vaccinated at regular intervals. ...
... For some diseases you only need to be vaccinated once in your life. For other diseases you need to be vaccinated at regular intervals. ...
Press release - Austria Center Vienna
... pioneering work has helped to save millions of lives and enabled countless children of parents with critical rhesus incompatibilities to lead normal lives. The pioneers of immune research in Vienna at the turn of the century will be the focus of an exhibition entitled Emerging Immunology – Vienna’s ...
... pioneering work has helped to save millions of lives and enabled countless children of parents with critical rhesus incompatibilities to lead normal lives. The pioneers of immune research in Vienna at the turn of the century will be the focus of an exhibition entitled Emerging Immunology – Vienna’s ...
Bionor Pharma
... Prevents, treats, and potentially cures some of the world’s most deadly viruses ...
... Prevents, treats, and potentially cures some of the world’s most deadly viruses ...
Similarities and differences between developing countries and
... of the number of deaths around the world. • indicators used: • infant mortality rate (for infants under 12 months of age • under-five mortality rate (U5MR) • maternal mortality ratio (MMR). • Adult mortality ...
... of the number of deaths around the world. • indicators used: • infant mortality rate (for infants under 12 months of age • under-five mortality rate (U5MR) • maternal mortality ratio (MMR). • Adult mortality ...
IBD-SSHAMP
... • NB - Faecal Calprotectin 93% sensitive and 96% specific at differentiating between Functional and Organic bowel disease (MBJ Meta-anaysis. 2010;341:c3369) • Calprotectin can be used to predict a flare as the levels rise 2-3m before the symptomatic flare occurs (Tibble J. Gastro. 2000; 119:15-22). ...
... • NB - Faecal Calprotectin 93% sensitive and 96% specific at differentiating between Functional and Organic bowel disease (MBJ Meta-anaysis. 2010;341:c3369) • Calprotectin can be used to predict a flare as the levels rise 2-3m before the symptomatic flare occurs (Tibble J. Gastro. 2000; 119:15-22). ...
Appearance of peripheral blood plasma cells and memory B cells in
... persons receiving their third immunization in the naive group, 56 days after the first dose, where a rise was seen as early as day 4. This may reflect faster activation of recently generated memory B cells either in extrafollicular foci or after reentry in GCs23,24; or activity of partially involute ...
... persons receiving their third immunization in the naive group, 56 days after the first dose, where a rise was seen as early as day 4. This may reflect faster activation of recently generated memory B cells either in extrafollicular foci or after reentry in GCs23,24; or activity of partially involute ...
New Zealand Health Declaration
... 4. Is there on board or has there been during the voyage* any case of disease which you suspect to be of an infectious nature? Give particulars in the Schedule. 5. Is there any sick person on board now? Give particulars in the Schedule. Note: In the absence of a surgeon, the Master should regard the ...
... 4. Is there on board or has there been during the voyage* any case of disease which you suspect to be of an infectious nature? Give particulars in the Schedule. 5. Is there any sick person on board now? Give particulars in the Schedule. Note: In the absence of a surgeon, the Master should regard the ...
APUnit9sheet2017
... 5. Explain how memory cells play a role in a secondary immune response. Chapter 19 – Viruses 1. Compare and contrast the hosts and structures of Fig. 19.3 viruses with the basic virus structure. 2. What is the basic sequence of a viral life cycle? 3. What are characteristics of and diseases caused b ...
... 5. Explain how memory cells play a role in a secondary immune response. Chapter 19 – Viruses 1. Compare and contrast the hosts and structures of Fig. 19.3 viruses with the basic virus structure. 2. What is the basic sequence of a viral life cycle? 3. What are characteristics of and diseases caused b ...
Infectious Bronchitis in Poultry: Constraints and Biotechnological
... PRRs, the Mannose-Binding Lectin (MBL) is abundant in the infectious process. It recognizes carbohydrates expressed by many pathogens (viruses, bacteria or parasites) (Juul-Madsen et al., 2011). Increasing serum levels is associated with resistance to several diseases including IB (Kjaerup et al., 2 ...
... PRRs, the Mannose-Binding Lectin (MBL) is abundant in the infectious process. It recognizes carbohydrates expressed by many pathogens (viruses, bacteria or parasites) (Juul-Madsen et al., 2011). Increasing serum levels is associated with resistance to several diseases including IB (Kjaerup et al., 2 ...
The Immune System
... Defense Against Infections & Disease • Our bodies are always ready to defend against invasion—the first line of defense is our skin and other bodily secretions (mucus, tears, sweat and saliva) – Mucus acts as a trap where microorganisms are swallowed and then digested – Tears, sweat and saliva all ...
... Defense Against Infections & Disease • Our bodies are always ready to defend against invasion—the first line of defense is our skin and other bodily secretions (mucus, tears, sweat and saliva) – Mucus acts as a trap where microorganisms are swallowed and then digested – Tears, sweat and saliva all ...
Case Study 1- What is the basis of autoimmune diseases (list 4
... Galas Dorota Kent State University ...
... Galas Dorota Kent State University ...
Fermentative Production of Natural and Unnatural Flavonoids by
... studies in vitro and in vivo have shown that whole mycobacteria or mycobacterial components as agonists for TLRs. Our recent studies have revealed the intracellular signaling cascades involved in the TLR-initiated immune response to mycobacterial infection. In addition, we are trying to explore the ...
... studies in vitro and in vivo have shown that whole mycobacteria or mycobacterial components as agonists for TLRs. Our recent studies have revealed the intracellular signaling cascades involved in the TLR-initiated immune response to mycobacterial infection. In addition, we are trying to explore the ...
Design of new vaccines in the genomic and post
... phase variation and sequence conservation in a panel of genetically diverse MenB strains representative of the global diversity of the natural N. meningitidis population. From this analysis, five antigens were found to be conserved in sequence among the panel of strains tested and were able to elici ...
... phase variation and sequence conservation in a panel of genetically diverse MenB strains representative of the global diversity of the natural N. meningitidis population. From this analysis, five antigens were found to be conserved in sequence among the panel of strains tested and were able to elici ...
SAG-2 oral rabies vaccine A. J. BARRAT
... SAG-2 could induce rabies. Recently SAG-2 was shown to be non-pathogenic for baboons (Bingham ...
... SAG-2 could induce rabies. Recently SAG-2 was shown to be non-pathogenic for baboons (Bingham ...
Antibiotics
... Erythromycin and tetracycline – interfere with protein synthesis Rifampin – inhibits RNA synthesis ...
... Erythromycin and tetracycline – interfere with protein synthesis Rifampin – inhibits RNA synthesis ...
New Strategies for Vaccine Development - Initial Set Up
... by conventional vaccination approaches. Recent knowledge of host-pathogen interactions, received from fundamental research in immunology, molecular-cellular biology and vaccinology provides understanding that the induction of T-cell immunity is required for optimal treatment against pathogens causi ...
... by conventional vaccination approaches. Recent knowledge of host-pathogen interactions, received from fundamental research in immunology, molecular-cellular biology and vaccinology provides understanding that the induction of T-cell immunity is required for optimal treatment against pathogens causi ...
FluMist, Influenza Virus Vaccine Live, Intranasal
... health care professional administering the vaccine to review them. FluMist should only be administered to people age 5 to 49 years old who are healthy. Certain people must not receive FluMist. You must answer each question below, and have the answers reviewed by the health care professional to ensur ...
... health care professional administering the vaccine to review them. FluMist should only be administered to people age 5 to 49 years old who are healthy. Certain people must not receive FluMist. You must answer each question below, and have the answers reviewed by the health care professional to ensur ...
Press Release: Week 20 – Hepatitis Awareness Month
... Hepatitis or inflammation of the liver can be caused by viruses, medication, toxins, excessive alcohol intake but most commonly by viruses named Hepatitis A, B or C. Hepatitis A and B can be prevented by vaccination but there is no vaccine available to prevent Hepatitis C. Hepatitis C is a contagiou ...
... Hepatitis or inflammation of the liver can be caused by viruses, medication, toxins, excessive alcohol intake but most commonly by viruses named Hepatitis A, B or C. Hepatitis A and B can be prevented by vaccination but there is no vaccine available to prevent Hepatitis C. Hepatitis C is a contagiou ...
Infection Epidemiology
... Introduction to the aims and scope of infection epidemiology: main definitions used in epidemiological research and clinical practice. How to define which disease or pathogen is important? Link between laboratory and infectious diseases epidemiology. Transmission of pathogens. Risk factors, transmis ...
... Introduction to the aims and scope of infection epidemiology: main definitions used in epidemiological research and clinical practice. How to define which disease or pathogen is important? Link between laboratory and infectious diseases epidemiology. Transmission of pathogens. Risk factors, transmis ...
Immunization Competencies Education Program Module 1
... Long-term immunity with vaccination is only possible through the maintenance of antigen-specific immune memory cells that may be sufficiently efficient and can rapidly reactivate into immune effector cells when exposed to the natural disease.5 Vaccines can be made from inactivated (killed) or attenu ...
... Long-term immunity with vaccination is only possible through the maintenance of antigen-specific immune memory cells that may be sufficiently efficient and can rapidly reactivate into immune effector cells when exposed to the natural disease.5 Vaccines can be made from inactivated (killed) or attenu ...
Feel Your Best with the BOOM!
... and Asian superfood, Wakame • Gives serious defense against free radicals with naturally sourced antioxidants from Acerola and Wild Bush Plum* • Is FREE of gluten, dairy, soy and synthetics with no artificial flavors, colors or sweeteners ...
... and Asian superfood, Wakame • Gives serious defense against free radicals with naturally sourced antioxidants from Acerola and Wild Bush Plum* • Is FREE of gluten, dairy, soy and synthetics with no artificial flavors, colors or sweeteners ...
Vaccination
Vaccination is the administration of antigenic material (a vaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate morbidity from infection. When a sufficiently large percentage of a population has been vaccinated, this results in herd immunity. The effectiveness of vaccination has been widely studied and verified; for example, the influenza vaccine, the HPV vaccine, and the chicken pox vaccine. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the restriction of diseases such as polio, measles, and tetanus from much of the world. The World Health Organization (WHO) reports that licensed vaccines are currently available to prevent or contribute to the prevention and control of twenty-five infections.The active agent of a vaccine may be intact but inactivated (non-infective) or attenuated (with reduced infectivity) forms of the causative pathogens, or purified components of the pathogen that have been found to be highly immunogenic (e.g., outer coat proteins of a virus). Toxoids are produced for immunization against toxin-based diseases, such as the modification of tetanospasmin toxin of tetanus to remove its toxic effect but retain its immunogenic effect.Smallpox was most likely the first disease people tried to prevent by inoculating themselves and was the first disease for which a vaccine was produced. The smallpox vaccine was discovered in 1796 by the British physician Edward Jenner, although at least six people had used the same principles years earlier. Louis Pasteur furthered the concept through his work in microbiology. The immunization was called vaccination because it was derived from a virus affecting cows (Latin: vacca—cow). Smallpox was a contagious and deadly disease, causing the deaths of 20–60% of infected adults and over 80% of infected children. When smallpox was finally eradicated in 1979, it had already killed an estimated 300–500 million people in the 20th century.In common speech, 'vaccination' and 'immunization' have a similar meaning. This distinguishes it from inoculation, which uses unweakened live pathogens, although in common usage either can refer to an immunization. Vaccination efforts have been met with some controversy on scientific, ethical, political, medical safety, and religious grounds. In rare cases, vaccinations can injure people and, in the United States, they may receive compensation for those injuries under the National Vaccine Injury Compensation Program. Early success and compulsion brought widespread acceptance, and mass vaccination campaigns have greatly reduced the incidence of many diseases in numerous geographic regions.